PDB Short entry for 2FO4
HEADER    IMMUNE SYSTEM                           12-JAN-06   2FO4              
TITLE     ENHANCED MHC CLASS I BINDING AND IMMUNE RESPONSES THROUGH ANCHOR      
TITLE    2 MODIFICATION OF THE NON-CANONICAL TUMOR ASSOCIATED MUC1-8 PEPTIDE    
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B ALPHA CHAIN;   
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: EXTRACELLULAR DOMAINS, RESIDUES 1-274;                     
COMPND   5 SYNONYM: H-2KB;                                                      
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 MOL_ID: 2;                                                           
COMPND   8 MOLECULE: BETA-2-MICROGLOBULIN;                                      
COMPND   9 CHAIN: B;                                                            
COMPND  10 ENGINEERED: YES;                                                     
COMPND  11 MOL_ID: 3;                                                           
COMPND  12 MOLECULE: 8-MER FROM MUCIN-1;                                        
COMPND  13 CHAIN: P;                                                            
COMPND  14 SYNONYM: MUCIN 1, TRANSMEMBRANE, MUC-1, POLYMORPHIC EPITHELIAL MUCIN,
COMPND  15 PEM, PEMT, EPISIALIN, TUMOR-ASSOCIATED MUCIN, CARCINOMA-ASSOCIATED   
COMPND  16 MUCIN, TUMOR-ASSOCIATED EPITHELIAL MEMBRANE ANTIGEN, EMA, H23AG,     
COMPND  17 PEANUT- REACTIVE URINARY MUCIN, PUM, BREAST CARCINOMA-ASSOCIATED     
COMPND  18 ANTIGEN DF3, CD227 ANTIGEN;                                          
COMPND  19 ENGINEERED: YES;                                                     
COMPND  20 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: MUS MUSCULUS;                                   
SOURCE   3 ORGANISM_COMMON: HOUSE MOUSE;                                        
SOURCE   4 ORGANISM_TAXID: 10090;                                               
SOURCE   5 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER;                          
SOURCE   6 EXPRESSION_SYSTEM_COMMON: FRUIT FLY;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 7227;                                       
SOURCE   8 EXPRESSION_SYSTEM_STRAIN: SC2 CELLS;                                 
SOURCE   9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  10 EXPRESSION_SYSTEM_PLASMID: PRMHA-3;                                  
SOURCE  11 MOL_ID: 2;                                                           
SOURCE  12 ORGANISM_SCIENTIFIC: MUS MUSCULUS;                                   
SOURCE  13 ORGANISM_COMMON: HOUSE MOUSE;                                        
SOURCE  14 ORGANISM_TAXID: 10090;                                               
SOURCE  15 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER;                          
SOURCE  16 EXPRESSION_SYSTEM_COMMON: FRUIT FLY;                                 
SOURCE  17 EXPRESSION_SYSTEM_TAXID: 7227;                                       
SOURCE  18 EXPRESSION_SYSTEM_STRAIN: SC2 CELLS;                                 
SOURCE  19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  20 EXPRESSION_SYSTEM_PLASMID: PRMHA-3;                                  
SOURCE  21 MOL_ID: 3;                                                           
SOURCE  22 SYNTHETIC: YES;                                                      
SOURCE  23 OTHER_DETAILS: THE 8-RESIDUE PEPTIDE OF MUCIN 1 WAS CHEMICALLY       
SOURCE  24 SYNTHESIZED.                                                         
KEYWDS    ANCHOR MODIFICATIONS, H-2KB, MUC1, NON-CANONICAL PEPTIDE, MUC1-8,     
KEYWDS   2 VACCINE DESIGN, IMMUNE SYSTEM                                        
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    E.LAZOURA,P.A.RAMSLAND                                                
REVDAT   7   25-OCT-23 2FO4    1       REMARK                                   
REVDAT   6   10-NOV-21 2FO4    1       SEQADV HETSYN                            
REVDAT   5   29-JUL-20 2FO4    1       COMPND REMARK HETNAM LINK                
REVDAT   5 2                   1       SITE   ATOM                              
REVDAT   4   18-OCT-17 2FO4    1       REMARK                                   
REVDAT   3   13-JUL-11 2FO4    1       VERSN                                    
REVDAT   2   24-FEB-09 2FO4    1       VERSN                                    
REVDAT   1   14-NOV-06 2FO4    0                                                
JRNL        AUTH   E.LAZOURA,J.LODDING,W.FARRUGIA,P.A.RAMSLAND,J.STEVENS,       
JRNL        AUTH 2 I.A.WILSON,G.A.PIETERSZ,V.APOSTOLOPOULOS                     
JRNL        TITL   ENHANCED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I BINDING    
JRNL        TITL 2 AND IMMUNE RESPONSES THROUGH ANCHOR MODIFICATION OF THE      
JRNL        TITL 3 NON-CANONICAL TUMOUR-ASSOCIATED MUCIN 1-8 PEPTIDE            
JRNL        REF    IMMUNOLOGY                    V. 119   306 2006              
JRNL        REFN                   ISSN 0019-2805                               
JRNL        PMID   17067310                                                     
JRNL        DOI    10.1111/J.1365-2567.2006.02434.X                             
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.70 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS                                                  
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : ENGH & HUBER                                    
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 41.80                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : NULL                           
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : NULL                           
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 94.3                           
REMARK   3   NUMBER OF REFLECTIONS             : 14860                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.193                           
REMARK   3   FREE R VALUE                     : 0.248                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : NULL                            
REMARK   3   FREE R VALUE TEST SET COUNT      : 1449                            
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL                            
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : NULL                         
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.70                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.87                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 78.10                        
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : NULL                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2850                       
REMARK   3   BIN FREE R VALUE                    : 0.3470                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : NULL                         
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 181                          
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.026                        
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 3117                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 80                                      
REMARK   3   SOLVENT ATOMS            : 103                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 54.40                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 37.50                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : 0.28                            
REMARK   3   ESD FROM SIGMAA              (A) : 0.34                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : 5.00                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.38                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.44                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.006                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.400                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 24.70                           
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.790                           
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : ISOTROPIC                                 
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : NULL                                                 
REMARK   3   KSOL        : NULL                                                 
REMARK   3   BSOL        : NULL                                                 
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2FO4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-JAN-06.                  
REMARK 100 THE DEPOSITION ID IS D_1000036107.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 17-FEB-05                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 6.6                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : N                                  
REMARK 200  RADIATION SOURCE               : ROTATING ANODE                     
REMARK 200  BEAMLINE                       : NULL                               
REMARK 200  X-RAY GENERATOR MODEL          : RIGAKU                             
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : MIRRORS                            
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : RIGAKU RAXIS IV                    
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : R-AXIS                             
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 14860                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.700                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 97.9                               
REMARK 200  DATA REDUNDANCY                : 6.400                              
REMARK 200  R MERGE                    (I) : 0.10400                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 17.4000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.80                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 96.2                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 5.30                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.43400                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 3.300                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: CNS                                                   
REMARK 200 STARTING MODEL: PDB ENTRY 1G7Q                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 59.42                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.9M SODIUM/POTASIUM PHOSPHATE, 2%       
REMARK 280  MPD, PH 6.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K        
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2                        
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,-Y,Z                                                 
REMARK 290       3555   -X+1/2,Y+1/2,-Z                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000       67.63000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       43.94500            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       67.63000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       43.94500            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC                          
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC                   
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 6690 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 18550 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -75.0 KCAL/MOL                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P, C                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A  29     -129.70     67.53                                   
REMARK 500    SER A  38       -7.87    -56.78                                   
REMARK 500    TYR A 123      -70.71   -116.66                                   
REMARK 500    GLU A 196       65.13     80.34                                   
REMARK 500    ASP A 197       49.99     28.51                                   
REMARK 500    PRO A 210     -179.28    -65.38                                   
REMARK 500    ILE A 225      -54.30    -29.39                                   
REMARK 500    ARG A 273     -169.00   -113.39                                   
REMARK 500    PRO B  47     -101.43    -52.76                                   
REMARK 500    LYS B  48       85.81    -63.31                                   
REMARK 500    PRO P   7      144.16    -38.32                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1G7Q   RELATED DB: PDB                                   
REMARK 900 THE SAME PROTEIN COMPLEXED WITH MUC1-8 PEPTIDE                       
DBREF  2FO4 A    1   274  UNP    P01901   HA1B_MOUSE      22    295             
DBREF  2FO4 B    1    99  UNP    P01887   B2MG_MOUSE      21    119             
DBREF  2FO4 P    1     8  UNP    Q16615   MUC1_HUMAN     920    927             
SEQADV 2FO4 PHE P    5  UNP  Q16615    THR   924 ENGINEERED MUTATION            
SEQADV 2FO4 LEU P    8  UNP  Q16615    ALA   927 ENGINEERED MUTATION            
SEQRES   1 A  274  GLY PRO HIS SER LEU ARG TYR PHE VAL THR ALA VAL SER          
SEQRES   2 A  274  ARG PRO GLY LEU GLY GLU PRO ARG TYR MET GLU VAL GLY          
SEQRES   3 A  274  TYR VAL ASP ASP THR GLU PHE VAL ARG PHE ASP SER ASP          
SEQRES   4 A  274  ALA GLU ASN PRO ARG TYR GLU PRO ARG ALA ARG TRP MET          
SEQRES   5 A  274  GLU GLN GLU GLY PRO GLU TYR TRP GLU ARG GLU THR GLN          
SEQRES   6 A  274  LYS ALA LYS GLY ASN GLU GLN SER PHE ARG VAL ASP LEU          
SEQRES   7 A  274  ARG THR LEU LEU GLY TYR TYR ASN GLN SER LYS GLY GLY          
SEQRES   8 A  274  SER HIS THR ILE GLN VAL ILE SER GLY CYS GLU VAL GLY          
SEQRES   9 A  274  SER ASP GLY ARG LEU LEU ARG GLY TYR GLN GLN TYR ALA          
SEQRES  10 A  274  TYR ASP GLY CYS ASP TYR ILE ALA LEU ASN GLU ASP LEU          
SEQRES  11 A  274  LYS THR TRP THR ALA ALA ASP MET ALA ALA LEU ILE THR          
SEQRES  12 A  274  LYS HIS LYS TRP GLU GLN ALA GLY GLU ALA GLU ARG LEU          
SEQRES  13 A  274  ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG          
SEQRES  14 A  274  ARG TYR LEU LYS ASN GLY ASN ALA THR LEU LEU ARG THR          
SEQRES  15 A  274  ASP SER PRO LYS ALA HIS VAL THR HIS HIS SER ARG PRO          
SEQRES  16 A  274  GLU ASP LYS VAL THR LEU ARG CYS TRP ALA LEU GLY PHE          
SEQRES  17 A  274  TYR PRO ALA ASP ILE THR LEU THR TRP GLN LEU ASN GLY          
SEQRES  18 A  274  GLU GLU LEU ILE GLN ASP MET GLU LEU VAL GLU THR ARG          
SEQRES  19 A  274  PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA SER VAL          
SEQRES  20 A  274  VAL VAL PRO LEU GLY LYS GLU GLN TYR TYR THR CYS HIS          
SEQRES  21 A  274  VAL TYR HIS GLN GLY LEU PRO GLU PRO LEU THR LEU ARG          
SEQRES  22 A  274  TRP                                                          
SEQRES   1 B   99  ILE GLN LYS THR PRO GLN ILE GLN VAL TYR SER ARG HIS          
SEQRES   2 B   99  PRO PRO GLU ASN GLY LYS PRO ASN ILE LEU ASN CYS TYR          
SEQRES   3 B   99  VAL THR GLN PHE HIS PRO PRO HIS ILE GLU ILE GLN MET          
SEQRES   4 B   99  LEU LYS ASN GLY LYS LYS ILE PRO LYS VAL GLU MET SER          
SEQRES   5 B   99  ASP MET SER PHE SER LYS ASP TRP SER PHE TYR ILE LEU          
SEQRES   6 B   99  ALA HIS THR GLU PHE THR PRO THR GLU THR ASP THR TYR          
SEQRES   7 B   99  ALA CYS ARG VAL LYS HIS ASP SER MET ALA GLU PRO LYS          
SEQRES   8 B   99  THR VAL TYR TRP ASP ARG ASP MET                              
SEQRES   1 P    8  SER ALA PRO ASP PHE ARG PRO LEU                              
MODRES 2FO4 ASN A   86  ASN  GLYCOSYLATION SITE                                 
MODRES 2FO4 ASN A  176  ASN  GLYCOSYLATION SITE                                 
HET    NAG  C   1      14                                                       
HET    FUC  C   2      10                                                       
HET    NAG  A 900      14                                                       
HET    PO4  A2001       5                                                       
HET    PO4  A2002       5                                                       
HET    MPD  A1002       8                                                       
HET    MPD  A1004       8                                                       
HET    MPD  B1001       8                                                       
HET    MPD  B1003       8                                                       
HETNAM     NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE                         
HETNAM     FUC ALPHA-L-FUCOPYRANOSE                                             
HETNAM     PO4 PHOSPHATE ION                                                    
HETNAM     MPD (4S)-2-METHYL-2,4-PENTANEDIOL                                    
HETSYN     NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-           
HETSYN   2 NAG  D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO-          
HETSYN   3 NAG  2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE                         
HETSYN     FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L-              
HETSYN   2 FUC  FUCOSE; FUCOSE                                                  
FORMUL   4  NAG    2(C8 H15 N O6)                                               
FORMUL   4  FUC    C6 H12 O5                                                    
FORMUL   6  PO4    2(O4 P 3-)                                                   
FORMUL   8  MPD    4(C6 H14 O2)                                                 
FORMUL  12  HOH   *103(H2 O)                                                    
HELIX    1   1 ALA A   49  GLU A   55  5                                   7    
HELIX    2   2 GLY A   56  TYR A   85  1                                  30    
HELIX    3   3 ASP A  137  ALA A  150  1                                  14    
HELIX    4   4 GLY A  151  GLY A  162  1                                  12    
HELIX    5   5 GLY A  162  GLY A  175  1                                  14    
HELIX    6   6 GLY A  175  LEU A  180  1                                   6    
HELIX    7   7 ILE A  225  MET A  228  5                                   4    
HELIX    8   8 LYS A  253  TYR A  257  5                                   5    
SHEET    1   A 8 GLU A  46  PRO A  47  0                                        
SHEET    2   A 8 THR A  31  ASP A  37 -1  N  ARG A  35   O  GLU A  46           
SHEET    3   A 8 ARG A  21  VAL A  28 -1  N  VAL A  28   O  THR A  31           
SHEET    4   A 8 HIS A   3  VAL A  12 -1  N  PHE A   8   O  VAL A  25           
SHEET    5   A 8 THR A  94  VAL A 103 -1  O  CYS A 101   N  LEU A   5           
SHEET    6   A 8 LEU A 109  TYR A 118 -1  O  LEU A 110   N  GLU A 102           
SHEET    7   A 8 CYS A 121  LEU A 126 -1  O  ILE A 124   N  TYR A 116           
SHEET    8   A 8 TRP A 133  ALA A 135 -1  O  THR A 134   N  ALA A 125           
SHEET    1   B 4 LYS A 186  ARG A 194  0                                        
SHEET    2   B 4 LYS A 198  PHE A 208 -1  O  TRP A 204   N  HIS A 188           
SHEET    3   B 4 PHE A 241  PRO A 250 -1  O  ALA A 245   N  CYS A 203           
SHEET    4   B 4 GLU A 229  LEU A 230 -1  N  GLU A 229   O  SER A 246           
SHEET    1   C 4 LYS A 186  ARG A 194  0                                        
SHEET    2   C 4 LYS A 198  PHE A 208 -1  O  TRP A 204   N  HIS A 188           
SHEET    3   C 4 PHE A 241  PRO A 250 -1  O  ALA A 245   N  CYS A 203           
SHEET    4   C 4 ARG A 234  PRO A 235 -1  N  ARG A 234   O  GLN A 242           
SHEET    1   D 4 GLU A 222  GLU A 223  0                                        
SHEET    2   D 4 ILE A 213  LEU A 219 -1  N  LEU A 219   O  GLU A 222           
SHEET    3   D 4 THR A 258  HIS A 263 -1  O  HIS A 260   N  THR A 216           
SHEET    4   D 4 LEU A 270  LEU A 272 -1  O  LEU A 272   N  CYS A 259           
SHEET    1   E 4 GLN B   6  SER B  11  0                                        
SHEET    2   E 4 ASN B  21  PHE B  30 -1  O  ASN B  24   N  TYR B  10           
SHEET    3   E 4 PHE B  62  PHE B  70 -1  O  PHE B  62   N  PHE B  30           
SHEET    4   E 4 GLU B  50  PHE B  56 -1  N  SER B  55   O  TYR B  63           
SHEET    1   F 4 LYS B  44  LYS B  45  0                                        
SHEET    2   F 4 ILE B  35  LYS B  41 -1  N  LYS B  41   O  LYS B  44           
SHEET    3   F 4 TYR B  78  HIS B  84 -1  O  ALA B  79   N  LEU B  40           
SHEET    4   F 4 LYS B  91  TYR B  94 -1  O  LYS B  91   N  VAL B  82           
SSBOND   1 CYS A  101    CYS A  164                          1555   1555  2.04  
SSBOND   2 CYS A  203    CYS A  259                          1555   1555  2.02  
SSBOND   3 CYS B   25    CYS B   80                          1555   1555  2.03  
LINK         ND2 ASN A  86                 C1  NAG A 900     1555   1555  1.45  
LINK         ND2 ASN A 176                 C1  NAG C   1     1555   1555  1.45  
LINK         O6  NAG C   1                 C1  FUC C   2     1555   1555  1.40  
CISPEP   1 TYR A  209    PRO A  210          0         0.16                     
CISPEP   2 HIS B   31    PRO B   32          0         0.05                     
CRYST1  135.260   87.890   45.160  90.00  90.00  90.00 P 21 21 2     4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.007393  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.011378  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.022143        0.00000